Liver transplantation at the age of MELD [Lebertransplantation im Zeitalter von MELD]

被引:0
|
作者
Strassburg C.P. [1 ]
机构
[1] Klin. F. Gastroenterol., Hepatologie und Endokrinol. und Interdisziplinare Ambulanz F. Lebertransplantation, Medizinische Hochschule Hannover, 30625Hannover
来源
Der Gastroenterologe | 2009年 / 4卷 / 6期
关键词
Allocation; Hepatocellular carcinoma; Liver cirrhosis; MELD; Standard exception;
D O I
10.1007/s11377-009-0332-0
中图分类号
学科分类号
摘要
Liver transplantation represents a standard treatment option for irreversible chronic liver diseases. It is characterized by a shortage of donor allografts as well as by an increasing overall number of transplantations and indications, which necessitates that rationing of this therapeutic option has to occur. Since December 2006, the priority for liver transplantation is determined by the model for end stage liver disease (MELD) and not by the length of waiting time. MELD is a statistical model based on serum creatinine, serum bilirubin and coagulation, which describes the probability of 3-month mortality of a potential transplant candidate for all potential indication groups. MELD is supplemented by accepted standard exceptional categories. MELD upgrades the role of priority and need before transplantation and has led to substantial changes of the management of liver transplantation, the spectrum of indications and of post-operative mortality. The establishment and implementation of robust, objective and transparent systems to assess not only pre-operative priority but also post-operative benefit represents a major challenge for transplantation medicine. © 2009 Springer Medizin Verlag.
引用
收藏
页码:501 / 512
页数:11
相关论文
共 50 条
  • [41] MELD as a Metric for Survival Benefit of Liver Transplantation.
    Luo, X.
    Massie, A.
    Bae, S.
    Bowring, M.
    Segev, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 586 - 587
  • [42] MELD-Na and Survival Benefit in Liver Transplantation
    Vitale, A.
    Bertacco, A.
    Gambato, M.
    D'Amico, F.
    Morales, Ramirez R.
    Neri, D.
    Burra, P.
    Angeli, P.
    Cillo, U.
    TRANSPLANTATION, 2012, 94 (10) : 677 - 677
  • [43] Trends in meld score and transplantation rates under the meld system
    Freeman, R
    Edwards, EB
    Harper, AM
    HEPATOLOGY, 2005, 42 (04) : 203A - 203A
  • [44] MELD and prediction of post-liver transplantation survival
    Habib, S
    Berk, B
    Chang, CCH
    Demetris, AJ
    Fontes, P
    Dvorchik, I
    Eghtesad, B
    Marcos, A
    Shakil, AO
    LIVER TRANSPLANTATION, 2006, 12 (03) : 440 - 447
  • [45] Racial differences in liver transplantation outcomes in the MELD era
    Ananthakrishnan, Ashwin N.
    Saeian, Kia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (04): : 901 - 910
  • [46] MELD-NA AND SURVIVAL BENEFIT IN LIVER TRANSPLANTATION
    Vitale, A.
    Bertacco, A.
    Gambato, M.
    D'Amico, F.
    Morales, R. Ramirez
    Zanus, G.
    Neri, D.
    Burra, P.
    Angeli, P.
    Cillo, U.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S96 - S96
  • [47] MELD and other predictors of survival after liver transplantation
    Brandao, Ajacio
    Fuchs, Sandra C.
    Gleisner, Ana L.
    Marroni, C.
    Zanotelli, Maria L.
    Cantisani, Guido
    CLINICAL TRANSPLANTATION, 2009, 23 (02) : 220 - 227
  • [48] RECURRENT HEPATIC ENCEPHALOPATHY AS A MELD EXCEPTION FOR LIVER TRANSPLANTATION
    Ruiz, Isaac
    Tremblay, Melanie
    Huard, Genevieve
    Wang, Yu Shi
    Bissonnette, Julien
    Vincent, Catherine
    Bemeur, Chantal
    Rose, Christopher F.
    HEPATOLOGY, 2023, 78 : S286 - S287
  • [49] Impact of MELD Exception for HPS on Liver Transplantation Outcomes
    Goldberg, David S.
    Batra, Sachin
    Trotter, James
    Kawut, Steven M.
    Fallon, Michael B.
    HEPATOLOGY, 2013, 58 : 762A - 762A
  • [50] Critical Interaction between MELD and AFP in Liver Transplantation
    Marvin, M.
    Ferguson, N.
    Jones, C.
    Davis, E.
    Cannon, R.
    Brock, G.
    TRANSPLANTATION, 2014, 98 : 154 - 154